Hungarians conduct COVID drug experiments in space (article in Hungarian)

The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences’ Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full, and therefore not temporary, and emergency license from the U.S. Food and Drug Administration (FDA) in October 2020…


Hungarian InnoStudio Zrt., Which is the leading international player in space chemistry as a new industry and CycloLab Kft., The primary European manufacturer of the excipient of remdesivir, is the first in the world to investigate the possible effects of microgravity during the remdesivir-SBECD interaction.

Read the full Hungarian article on

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Social Media

Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.

Latest News & Events

Latest Articles

InnoStudio is cited in the C&EN article “Pharma goes to Space”

InnoStudio is cited in the C&EN article “Pharma goes to Space”

C&EN article by Shi En KimNovember 13, 2022 | A version of this story appeared in Volume 100, Issue 40 IN BRIEF: The lack of gravity in space opens up unique opportunities for drug design and development. With the influx of commercial entities providing access to...

Hungarians develop more effective COVID drugs in space

Hungarians develop more effective COVID drugs in space

Published May 7, 2021 on In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...